Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Rabusin

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Eclinicalmedicine|June 23, 2025
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET)Annarosa Soresina, Roberto Rondelli, Lucia Dora Notarangelo, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Internal Consistency and Floor/Ceiling Effects of the Gross Motor Function Measure for Use with Children Affected by Cancer: A Cross-Sectional StudyFrancesca Rossi, Monica Valle, Giovanni Galeoto, et al.
Pediatric Blood & Cancer|January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority TrialRoberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
Frontiers in Immunology|December 17, 2020
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case ReportSabina Cenciarelli, Valeria Calbi, Federica Barzaghi, et al.
Children (Basel, Switzerland)|September 27, 2025
Development of Functional Abilities Assessment in Paediatric Oncology (FAAP-O) Scale for Children and Adolescents Affected by CancerFrancesca Rossi, Monica Valle, Giulia Carlucci, et al.
Journal of Translational Medicine|February 13, 2024
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical modelsMario Capasso, Chiara Brignole, Vito A Lasorsa, et al.
The New England Journal of Medicine|April 5, 2023
GD2-CART01 for Relapsed or Refractory High-Risk NeuroblastomaFrancesca Del Bufalo, Biagio De Angelis, Ignazio Caruana, et al.
Cancer Research Communications|March 25, 2026
Mapping genomic heterogeneity in paediatric and adolescent-young adult sarcomas: insights from the Italian SAR-GEN2016 and SAR-GEN_ITA prospective multicenter trialsElisa Tirtei, Valeria Difilippo, Federico Divincenzo, et al.
Nature Medicine|February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiencyMaddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
Journal of Clinical Immunology|April 5, 2024
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET ReportJohn McDonnell, Kimberley Cousins, M Elizabeth M Younger, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Eclinicalmedicine|June 23, 2025
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET)Annarosa Soresina, Roberto Rondelli, Lucia Dora Notarangelo, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Internal Consistency and Floor/Ceiling Effects of the Gross Motor Function Measure for Use with Children Affected by Cancer: A Cross-Sectional StudyFrancesca Rossi, Monica Valle, Giovanni Galeoto, et al.
Pediatric Blood & Cancer|January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority TrialRoberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
Frontiers in Immunology|December 17, 2020
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case ReportSabina Cenciarelli, Valeria Calbi, Federica Barzaghi, et al.
Children (Basel, Switzerland)|September 27, 2025
Development of Functional Abilities Assessment in Paediatric Oncology (FAAP-O) Scale for Children and Adolescents Affected by CancerFrancesca Rossi, Monica Valle, Giulia Carlucci, et al.
Journal of Translational Medicine|February 13, 2024
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical modelsMario Capasso, Chiara Brignole, Vito A Lasorsa, et al.
The New England Journal of Medicine|April 5, 2023
GD2-CART01 for Relapsed or Refractory High-Risk NeuroblastomaFrancesca Del Bufalo, Biagio De Angelis, Ignazio Caruana, et al.
Cancer Research Communications|March 25, 2026
Mapping genomic heterogeneity in paediatric and adolescent-young adult sarcomas: insights from the Italian SAR-GEN2016 and SAR-GEN_ITA prospective multicenter trialsElisa Tirtei, Valeria Difilippo, Federico Divincenzo, et al.
Nature Medicine|February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiencyMaddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
Journal of Clinical Immunology|April 5, 2024
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET ReportJohn McDonnell, Kimberley Cousins, M Elizabeth M Younger, et al.
Pageof 8